Carmat Past Earnings Performance

Past criteria checks 0/6

Carmat's earnings have been declining at an average annual rate of -13.1%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 85.5% per year.

Key information

-13.1%

Earnings growth rate

-39.8%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate85.5%
Return on equity-419.0%
Net Margin-2,603.0%
Next Earnings Update23 Feb 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Carmat makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CKMT.F Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 222-62140
31 Mar 222-62130
31 Dec 212-62120
30 Sep 211-52120
30 Jun 210-42120
31 Mar 210-40110
31 Dec 200-37100
30 Sep 200-38120
30 Jun 200-40140
31 Mar 200-41130
31 Dec 190-43130
30 Sep 190-45120
30 Jun 190-47120
31 Mar 190-44110
31 Dec 180-42110
30 Sep 180-38100
30 Jun 180-3490
31 Mar 180-3280
31 Dec 170-2970
30 Sep 170-2870
30 Jun 170-2770
31 Mar 170-2570
31 Dec 160-2360
30 Sep 160-2160
30 Jun 160-2060
31 Mar 160-1960

Quality Earnings: CKMT.F is currently unprofitable.

Growing Profit Margin: CKMT.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CKMT.F is unprofitable, and losses have increased over the past 5 years at a rate of 13.1% per year.

Accelerating Growth: Unable to compare CKMT.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CKMT.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).


Return on Equity

High ROE: CKMT.F has a negative Return on Equity (-419.03%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.